Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects

Christoph Kalka, Haruchika Masuda, Tomono Takahashi, Rebecca Gordon, Oren M. Tepper, Edwin Gravereaux, Ann Pieczek, Hideki Iwaguro, Shin Ichiro Hayashi, Jeffrey M. Isner, Takayuki Asahara

Research output: Contribution to journalArticle

504 Citations (Scopus)

Abstract

Preclinical studies in animal models and early results of clinical trials in patients suggest that intramuscular injection of naked plasmid DNA encoding vascular endothelial growth factor (VEGF) can promote neovascularization of ischemic tissues. Such neovascularization has been attributed exclusively to sprout formation of endothelial cells derived from preexisting vessels. We investigated the hypothesis that VEGF gene transfer may also augment the population of circulating endothelial progenitor cells (EPCs). In patients with critical limb ischemia receiving VEGF gene transfer, gene expression was documented by a transient increase in plasma levels of VEGF. A culture assay documented a significant increase in EPCs (219%, P<0.001), whereas patients who received an empty vector had no change in circulating EPCs, as was the case for volunteers who received saline injections (VEGF versus empty vector, P<0.001; VEGF versus saline, P<0.005). Fluorescence-activated cell sorter analysis disclosed an overall increase of up to 30-fold in endothelial lineage markers KDR (VEGF receptor-2), VE- cadherin, CD34, α(v)β3, and E-selectin after VEGF gene transfer. Constitutive overexpression of VEGF in patients with limb ischemia augments the population of circulating EPCs. These findings support the notion that neovascularization of human ischemic tissues after angiogenic growth factor therapy is not limited to angiogenesis but involves circulating endothelial precursors that may home to ischemic foci and differentiate in situ through a process of vasculogenesis.

Original languageEnglish (US)
Pages (from-to)1198-1202
Number of pages5
JournalCirculation Research
Volume86
Issue number12
StatePublished - Jun 23 2000
Externally publishedYes

Fingerprint

Vascular Endothelial Growth Factor A
Blood Vessels
Growth
Genes
Ischemia
Extremities
Vascular Endothelial Growth Factor Receptor-2
E-Selectin
Endothelial Progenitor Cells
Angiogenesis Inducing Agents
Intramuscular Injections
Population
Volunteers
Intercellular Signaling Peptides and Proteins
Plasmids
Endothelial Cells
Animal Models
Fluorescence
Clinical Trials
Gene Expression

Keywords

  • Endothelial progenitor cells
  • Gene therapy
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Kalka, C., Masuda, H., Takahashi, T., Gordon, R., Tepper, O. M., Gravereaux, E., ... Asahara, T. (2000). Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circulation Research, 86(12), 1198-1202.

Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects. / Kalka, Christoph; Masuda, Haruchika; Takahashi, Tomono; Gordon, Rebecca; Tepper, Oren M.; Gravereaux, Edwin; Pieczek, Ann; Iwaguro, Hideki; Hayashi, Shin Ichiro; Isner, Jeffrey M.; Asahara, Takayuki.

In: Circulation Research, Vol. 86, No. 12, 23.06.2000, p. 1198-1202.

Research output: Contribution to journalArticle

Kalka, C, Masuda, H, Takahashi, T, Gordon, R, Tepper, OM, Gravereaux, E, Pieczek, A, Iwaguro, H, Hayashi, SI, Isner, JM & Asahara, T 2000, 'Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects', Circulation Research, vol. 86, no. 12, pp. 1198-1202.
Kalka, Christoph ; Masuda, Haruchika ; Takahashi, Tomono ; Gordon, Rebecca ; Tepper, Oren M. ; Gravereaux, Edwin ; Pieczek, Ann ; Iwaguro, Hideki ; Hayashi, Shin Ichiro ; Isner, Jeffrey M. ; Asahara, Takayuki. / Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects. In: Circulation Research. 2000 ; Vol. 86, No. 12. pp. 1198-1202.
@article{616bc4971d354eafb83a9f56041e3fe2,
title = "Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects",
abstract = "Preclinical studies in animal models and early results of clinical trials in patients suggest that intramuscular injection of naked plasmid DNA encoding vascular endothelial growth factor (VEGF) can promote neovascularization of ischemic tissues. Such neovascularization has been attributed exclusively to sprout formation of endothelial cells derived from preexisting vessels. We investigated the hypothesis that VEGF gene transfer may also augment the population of circulating endothelial progenitor cells (EPCs). In patients with critical limb ischemia receiving VEGF gene transfer, gene expression was documented by a transient increase in plasma levels of VEGF. A culture assay documented a significant increase in EPCs (219{\%}, P<0.001), whereas patients who received an empty vector had no change in circulating EPCs, as was the case for volunteers who received saline injections (VEGF versus empty vector, P<0.001; VEGF versus saline, P<0.005). Fluorescence-activated cell sorter analysis disclosed an overall increase of up to 30-fold in endothelial lineage markers KDR (VEGF receptor-2), VE- cadherin, CD34, α(v)β3, and E-selectin after VEGF gene transfer. Constitutive overexpression of VEGF in patients with limb ischemia augments the population of circulating EPCs. These findings support the notion that neovascularization of human ischemic tissues after angiogenic growth factor therapy is not limited to angiogenesis but involves circulating endothelial precursors that may home to ischemic foci and differentiate in situ through a process of vasculogenesis.",
keywords = "Endothelial progenitor cells, Gene therapy, Vascular endothelial growth factor",
author = "Christoph Kalka and Haruchika Masuda and Tomono Takahashi and Rebecca Gordon and Tepper, {Oren M.} and Edwin Gravereaux and Ann Pieczek and Hideki Iwaguro and Hayashi, {Shin Ichiro} and Isner, {Jeffrey M.} and Takayuki Asahara",
year = "2000",
month = "6",
day = "23",
language = "English (US)",
volume = "86",
pages = "1198--1202",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects

AU - Kalka, Christoph

AU - Masuda, Haruchika

AU - Takahashi, Tomono

AU - Gordon, Rebecca

AU - Tepper, Oren M.

AU - Gravereaux, Edwin

AU - Pieczek, Ann

AU - Iwaguro, Hideki

AU - Hayashi, Shin Ichiro

AU - Isner, Jeffrey M.

AU - Asahara, Takayuki

PY - 2000/6/23

Y1 - 2000/6/23

N2 - Preclinical studies in animal models and early results of clinical trials in patients suggest that intramuscular injection of naked plasmid DNA encoding vascular endothelial growth factor (VEGF) can promote neovascularization of ischemic tissues. Such neovascularization has been attributed exclusively to sprout formation of endothelial cells derived from preexisting vessels. We investigated the hypothesis that VEGF gene transfer may also augment the population of circulating endothelial progenitor cells (EPCs). In patients with critical limb ischemia receiving VEGF gene transfer, gene expression was documented by a transient increase in plasma levels of VEGF. A culture assay documented a significant increase in EPCs (219%, P<0.001), whereas patients who received an empty vector had no change in circulating EPCs, as was the case for volunteers who received saline injections (VEGF versus empty vector, P<0.001; VEGF versus saline, P<0.005). Fluorescence-activated cell sorter analysis disclosed an overall increase of up to 30-fold in endothelial lineage markers KDR (VEGF receptor-2), VE- cadherin, CD34, α(v)β3, and E-selectin after VEGF gene transfer. Constitutive overexpression of VEGF in patients with limb ischemia augments the population of circulating EPCs. These findings support the notion that neovascularization of human ischemic tissues after angiogenic growth factor therapy is not limited to angiogenesis but involves circulating endothelial precursors that may home to ischemic foci and differentiate in situ through a process of vasculogenesis.

AB - Preclinical studies in animal models and early results of clinical trials in patients suggest that intramuscular injection of naked plasmid DNA encoding vascular endothelial growth factor (VEGF) can promote neovascularization of ischemic tissues. Such neovascularization has been attributed exclusively to sprout formation of endothelial cells derived from preexisting vessels. We investigated the hypothesis that VEGF gene transfer may also augment the population of circulating endothelial progenitor cells (EPCs). In patients with critical limb ischemia receiving VEGF gene transfer, gene expression was documented by a transient increase in plasma levels of VEGF. A culture assay documented a significant increase in EPCs (219%, P<0.001), whereas patients who received an empty vector had no change in circulating EPCs, as was the case for volunteers who received saline injections (VEGF versus empty vector, P<0.001; VEGF versus saline, P<0.005). Fluorescence-activated cell sorter analysis disclosed an overall increase of up to 30-fold in endothelial lineage markers KDR (VEGF receptor-2), VE- cadherin, CD34, α(v)β3, and E-selectin after VEGF gene transfer. Constitutive overexpression of VEGF in patients with limb ischemia augments the population of circulating EPCs. These findings support the notion that neovascularization of human ischemic tissues after angiogenic growth factor therapy is not limited to angiogenesis but involves circulating endothelial precursors that may home to ischemic foci and differentiate in situ through a process of vasculogenesis.

KW - Endothelial progenitor cells

KW - Gene therapy

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=0034705367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034705367&partnerID=8YFLogxK

M3 - Article

VL - 86

SP - 1198

EP - 1202

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 12

ER -